Get started
Author

Tomoko Yanai

Observed names: T. Yanai, TOMOKO YANAI
ORCID: 0000-0002-2753-5078
Observed ORCID: 0000-0002-2753-5078
OpenAlex ID: A5010342212
Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development
2016 · Okito Hashimoto, Makiko Yoshida, et al. · The Journal of Pathology · 190
PDF
The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman’s disease
2014 · Ikuko Kubokawa, Akihiro Yachie, et al. · BMC Pediatrics · 57
PDF
Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients
2008 · Katsuyasu Saigo, Yasuyuki Sakota, et al. · Transfusion and Apheresis Science · 52
PDF
Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells
2011 · Noriyuki Nishimura, Tri Budi Hartomo, et al. · Environmental Health and Preventive Medicine · 36
PDF
Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells
2013 · TRI BUDI HARTOMO, AIKO KOZAKI, et al. · Oncology Reports · 29
PDF
Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study
2019 · Noriko Fukuhara, Go Yamamoto, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 24
Association of Genetic Polymorphisms With Hepatotoxicity in Patients With Childhood Acute Lymphoblastic Leukemia or Lymphoma
2010 · Masanori Horinouchi, Mariko Yagi, et al. · Pediatric Hematology and Oncology · 20
High Level of Ezrin mRNA Expression in an Osteosarcoma Biopsy Sample With Lung Metastasis
2007 · Wakako Ogino, Yasuhiro Takeshima, et al. · Journal of Pediatric Hematology/Oncology · 20
Safety, Tolerability, and Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Inhibitor, in Patients with Advanced Solid Tumors: A Phase I First-in-Human Study
2022 · Yasutoshi Kuboki, Toshio Shimizu, et al. · Cancer Research Communications · 16
Primary pediatric stage III renal diffuse large B-cell lymphoma
2013 · Akira Hayakawa, Nobuya Shimotake, et al. · American Journal of Case Reports · 14
Early detection of tumor relapse/regrowth by consecutive minimal residual disease monitoring in high-risk neuroblastoma patients
2016 · Satoshi Hirase, Atsuro Saitoh, et al. · Oncology Letters · 13
PDF
Sterility Testing of Stem Cell Products by Broad-Range Bacterial 16S Ribosomal DNA Polymerase Chain Reaction
2015 · Osamu Tokuno, Akira Hayakawa, et al. · Laboratory Medicine · 11
Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients
2015 · NOBUYUKI YAMAMOTO, AIKO KOZAKI, et al. · Oncology Letters · 9
PDF
The emergence of CD20−/CD19− tumor cells after rituximab therapy for Epstein–Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis
2013 · Nobuyuki Yamamoto, Noriyuki Nishimura, et al. · European Journal of Pediatrics · 9
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies
2021 · Toshio Shimizu, Yasutoshi Kuboki, et al. · Targeted Oncology · 7
PDF
Hematopoietic Stem Cell Transplantation and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma
2019 · Kenichi Ishizawa, Tomoko Yanai · Advances in Therapy · 7
PDF
Primary pediatric endobronchial Ewing sarcoma family of tumors
2013 · Akira Hayakawa, Satoshi Hirase, et al. · American Journal of Case Reports · 7
Persistent detection of a novel MLL–SACM1L rearrangement in the absence of leukemia
2010 · Takeshi Mori, Noriyuki Nishimura, et al. · Leukemia Research · 7
PDF
Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia
2015 · Satoshi Hirase, Daiichiro Hasegawa, et al. · International Journal of Hematology · 6
Congenital cardiovascular malformations are complicated in neuroblastomas identified by mass screening but not by clinical examination in Japan
2006 · Tomoko Yanai, Daiichiro Hasegawa, et al. · The Journal of Pediatrics · 5
PDF
Place of death of pediatric cancer patients in a single institute during 7 years.
2012 · Tomoko Yanai, Satoshi Hirase, et al. · PubMed · 4
PDF
Utility of multiplex PCR in detecting the causative pathogens for pediatric febrile neutropenia.
2011 · Yoshihiro Mitsuda, Yasuhiro Takeshima, et al. · PubMed · 4
PDF
An Evans Syndrome Case Expressing Anti-Jka Autoantibody under Condition of Primary IgA Immunodeficiency
2015 · Takeshi Sugimoto, Ayumi Tani, et al. · International Journal of Clinical Medicine · 2
PDF
Absolute Lymphocyte Counts at the End of Induction Is a Prognostic Indicator in Childhood Acute Lymphoblastic Leukemia
2014 · Daiichiro Hasegawa, Satoshi Hirase, et al. · Blood · 1
Data from Safety, Tolerability, and Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Inhibitor, in Patients with Advanced Solid Tumors: A Phase I First-in-Human Study
2023 · Yasutoshi Kuboki, Toshio Shimizu, et al.
Works count: 46
Citation count: 550
H-index: 11
I10-index: 12
Year
Topic
Type